7.85

10.41% 0.74

Aspire Biopharma Holdings Inc (ASBP)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$7.11

Offen:

$7.15

24-Stunden-Volumen:

33,071

Relative Volume:

0.09

Marktkapitalisierung:

$10.17M

Einnahmen:

$34,600

Nettoeinkommen (Verlust:

$-11.76M

KGV:

-0.0511

EPS:

-153.5649

Netto-Cashflow:

$-6.21M

1W Leistung:

+1.55%

1M Leistung:

+30.18%

6M Leistung:

-81.70%

1J Leistung:

-98.32%

1-Tages-Spanne:

$7.14

$7.90

1-Wochen-Bereich:

$7.06

$8.00

52-Wochen-Spanne:

$3.309

$1,050.36

Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile

Firmenname

Aspire Biopharma Holdings Inc

Sektor

Healthcare (1080)

Branche

Biotechnology (604)

Telefon

561-704-8527

Adresse

23150 FASHION DRIVE, SUITE 232, ESTERO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-12

Neueste SEC-Einreichungen

ASBP's Discussions on Twitter

Compare ASBP vs VRTX, REGN, ARGX, RVMD, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ASBP Aspire Biopharma Holdings Inc	7.85	9.24M	34,600	-11.76M	-6.21M	-153.56
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten

Aug 14, 2026

S&R Associates Advises MiddleGround Capital on Sale of Dura Driver Control Systems to Aspire Biopharma Holdings - SCC Online

Aug 14, 2026

Aug 13, 2026

Aspire Biopharma (NASDAQ: ASBP) slashes H1 2026 loss and rebuilds equity - Stock Titan

Aug 13, 2026

Aspire Biopharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th - ACCESS Newswire

Aug 13, 2026

Aug 11, 2026

S&R Associates represented MiddleGround Capital - Lexology

Aug 11, 2026

ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits

Aug 11, 2026

LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits

Aug 11, 2026

ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - Stocktwits

Aug 11, 2026

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - Watertown Public Opinion

Aug 11, 2026

Aug 10, 2026

EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal - Yahoo Finance

Aug 10, 2026

Form 8K Aspire Biopharma Holdings Inc For: 10 August By Investing.com - Investing.com Nigeria

Aug 10, 2026

Aspire Biopharma Completes $30 Million Acquisition of Dura Driver Control Systems - citybiz

Aug 10, 2026

Aspire Biopharma Closes Acquisition of FireFish Units Under Asset and Equity Purchase Agreement - TradingView

Aug 10, 2026

Aspire Biopharma completes $30M automotive supplier acquisition - Investing.com

Aug 10, 2026

Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire

Aug 10, 2026

Aug 09, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - The Northwest Florida Daily News

Aug 09, 2026

Aug 08, 2026

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements - 富途牛牛

Aug 08, 2026

Jul 31, 2026